These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8836110)

  • 1. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.
    Schott H; Schwendener RA
    Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
    Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
    Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-beta-D-arabinofuranosylcytosine conjugates of ether and thioether phospholipids. A new class of ara-C prodrug with improved antitumor activity.
    Hong CI; West CR; Bernacki RJ; Tebbi CK; Berdel WE
    Lipids; 1991 Dec; 26(12):1437-44. PubMed ID: 1819747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model.
    Schwendener RA; Schott H
    J Cancer Res Clin Oncol; 1996; 122(12):723-6. PubMed ID: 8954169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids.
    Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
    J Med Chem; 1990 May; 33(5):1380-6. PubMed ID: 2329558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine.
    Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi J; Ishida T
    Cancer Res; 1976 Aug; 36(8):2726-32. PubMed ID: 1277182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H
    Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
    Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Berdel WE
    J Med Chem; 1986 Oct; 29(10):2038-44. PubMed ID: 3761322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
    Hong CI; Kirisits AJ; Buchheit DJ; Nechaev A; West CR
    Cancer Drug Deliv; 1986; 3(2):101-13. PubMed ID: 3708534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileukemic activity of sulfonamide conjugates of arabinosylcytosine.
    Novotny L; Phillips OA; Rauko P; Miadokova E
    Exp Oncol; 2006 Dec; 28(4):293-8. PubMed ID: 17285113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein kinase C by 1-beta-D-arabinofuranosylcytosine conjugates of phospholipid.
    Lee KH; Jung YJ; Hong CI; Cho MH; Bai DH; Kim SH; Choi KY; Yu JH; Kim CM
    Int J Oncol; 2004 Jan; 24(1):193-9. PubMed ID: 14654957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y; Saito M; Fukushima H; Takeda Y; Hara T
    Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinofuranosylcytosine.
    Schwendener RA; Horber DH; Odermatt B; Schott H
    J Cancer Res Clin Oncol; 1996; 122(2):102-8. PubMed ID: 8576276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent.
    Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi JI; Ishida T
    Cancer Res; 1977 Aug; 37(8 Pt 1):2481-6. PubMed ID: 872077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions with human blood in vitro and pharmacokinetic properties in mice of liposomal N4-octadecyl-1-beta-D-arabinofuranosylcytosine, a new anticancer drug.
    Koller-Lucae SK; Schott H; Schwendener RA
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1572-80. PubMed ID: 9316874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosine.
    Schwendener RA; Schott H
    Int J Cancer; 1992 May; 51(3):466-9. PubMed ID: 1592536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity, cell-cycle perturbations and apoptosis in human tumor cells by lipophilic N4-alkyl-1-beta-D-arabinofuranosylcytosine derivatives and the new heteronucleoside phosphate dimer arabinocytidylyl-(5'-->5')-N4-octadecyl-1-beta-D-arabinofuranosylcytosi ne.
    Horber DH; Cattaneo-Pangrazzi RM; von Ballmoos P; Schott H; Ludwig PS; Eriksson S; Fichtner I; Schwendener RA
    J Cancer Res Clin Oncol; 2000 Jun; 126(6):311-9. PubMed ID: 10870640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells.
    Tsuruo T; Iida H; Hori K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1981 Nov; 41(11 Pt 1):4484-8. PubMed ID: 7306971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-beta-D-arabinofuranosylcytosine-phospholipid conjugates as prodrugs of Ara-C.
    Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Ryu EK; MacCoss M
    Cancer Drug Deliv; 1984; 1(3):181-90. PubMed ID: 6544120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.